Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Revolutionizing Egyptian oil exploration

TAG Oil’s Tech-Driven Breakthrough In the vast expanse of Egypt’s Western Desert, a hidden treasure of oil and gas resources lies in wait, largely untapped until now. The Badr oil field (BED-1) in the Western Desert holds the promisi...
Research | December 19, 2023 |

What is the future of oil and gas?

Population growth will be a massive factor on increased energy demands The International Energy Agency states that at present we are “maintaining the 2021 energy crisis” The push for renewables as we head towards 2050 doesn&CloseC...
Coreena Robertson | 5 days ago |

Phase 2 Data from Potential Multibagger Biopharma 'Checks All the Boxes'

The latest clinical trial results are dissected in a ROTH Capital Partners report. In a Sept. 26 research note, ROTH Capital Partners analyst Jerry Isaacson reported that AzurRx BioPharma Inc.'s (AZRX:NASDAQ) Phase 2 OPTION trial for lead candidate MS1819 in cystic ...
Streetwise Reports | October 1, 2019 |

Prominent Gold Stock at 'Buy Spot'

Technical analyst Clive Maund's charts explain why he sees this stock as a buy. Tanzanian Gold Corp. (TRX:NYSE; TNX:TSX) looks like it is at an optimum buy spot right now , for reasons that are set out on its latest 6-month chart below. Because the nearby st...
Streetwise Reports | October 16, 2019 |

Buzz on the Bullboards: Quarterly reporting season at large

It has been another interesting week for markets on Bay Street and Wall Street, from a hot streak to a slide, back up, and down again. Every sector has seen its share of gainers and decliners, with the Stockhouse Bullboards tracking movement in all directions. A few mains...
Jonathon Brown | November 16, 2023 |

Oil speculators can profit from new Iranian sanctions

Growing up in Massachusetts, my mother used to say, "Live long enough, and you'll see just about anything happen in politics." And she was right. A wrestler, a standup comic, several movie actors, and former sports figures have been elected to office; t...
Kent Moors | October 28, 2012 |

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

This Signal Points To More Upside In Stocks

NEW MONTHLY SIGNALS The MSCI World Index tracks over one thousand large and mid-cap stocks in twenty-two developed countries, covering 85% of the market capitalization in those regions. As shown via the chart below, a positive monthly MACD cross was just nailed down on the...
Chris Ciovacco | December 3, 2019 |

NASDAQ Listing & $100M Sales Guidance Fuels Peak’s H2/21

eResearch is pleased to publish an update Equity Research Report on Peak Fintech Group (PKK) ( CSE.PKK , OTC: PKKFF , Forum ) pertaining to the recent release of its revenue & EBITDA guidance. We are maintaining our Speculative Buy rating and increasing our one-year pr...
Featured Submission | August 3, 2021 |

Global Central Banks Move To Keep The Party Rolling – Part III

This section of our multi-part article regarding current and past central bank actions, we are going to attempt to look at key elements of the past and present to highlight what we believe may turn out to be an incredible “setup” in the global markets. ...
Chris Vermeulen | August 14, 2019 |
1 2 3 4 5 6 7 8 9 10 ...